Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ARNA 4.17 +0.16 (3.99%)
price chart
4 High-Gross Margin Stocks: Arena Pharmaceuticals, Inc. (ARNA), Gastar ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has return on equity ratio of -54.10%. The company has $881.56 million in market worth.
Related articles »  
Hot Biotech Round Up: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared that facts from the stage 3 scientific test program for BELVIQ (lorcaserin HCl) CIV will be launched at the American College of Clinical Pharmacy (ACCP) yearly conference held on last ...
Investor's Alert: Arena Pharmaceuticals, Inc. (ARNA), FuelCell Energy ...  Techsonian (press release)
Related articles »  
Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA ...
Investor-Edge has initiated coverage on the following equities: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), XOMA Corporation (NASDAQ: XOMA), Momenta Pharmaceuticals Inc. (NASDAQ: MNTA), and ...
News Review: Merrimack Pharmaceuticals Inc(NASDAQ:MACK), NPS ...  Market News Call
Related articles »  
Pfizer Setback Could Help Arena
Yesterday, big pharma giant Pfizer (NYSE:PFE) received news from the FDA that a panel has taken the stance of recommending that a "black box" warning remain attached to the smoking cessation drug Chantix.
Related articles »  
Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5%
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) was a big mover last session, as the company saw its shares rise by nearly 10% on the day.
Related articles »  
Pharma Stocks to Watch: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Monday said data from phase 3 clinical trials of its obesity drug BELVIQ (lorcaserin HCl) will be presented at the American College of Clinical Pharmacy meeting taking place through Wednesday of this week.
Related articles »  
Belviq Sales Dip: What To Watch For Ahead
Sales of the Arena Pharmaceuticals (NASDAQ:ARNA) anti-obesity pill Belviq seem to be seeing some impacts of seasonality with ups and downs as the Fall weeks progress.
Investor Updates : Auxilium Pharma , Avanir Pharma , Arena Pharma , Novavax ...
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) : On October 2, Meeting held at Boston hosted by Jefferies. Auxilium (AUXL) downgraded to Sector Perform from Outperform at RBC Capital.
Related articles »  
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 13, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that data from the Phase 3 clinical trial program for BELVIQ� (lorcaserin HCl) CIV will be presented at the ...
Related articles »  
Arena Pharmaceuticals (ARNA) Flagged As Strong On High Volume
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors.
Related articles »